Back to calendar
Madrigal Pharmaceuticals, Inc. (MDGL) Earnings
MDGL reports earnings on Thursday, July 30, 2026
earnings report
July 30, 2026
Q2 2026
Est. EPS: $-0.82
Actual EPS: $-1.99
EPS surprise: 25.65%
Company overview
Market Cap$10.8B
PriceUSD 467.32
EPS (TTM)-12.88
52-week high615.00
52-week low299.17
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees915